The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 6120233 |
43 |
beta-Adrenergic blocking agents. alpha- and gamma-methyl(aryloxy)propanolamines. |
TBA |
| 26471092 |
23 |
Molecular hybridization yields triazole bronchodilators for the treatment of COPD. |
Pfizer |
| 25592716 |
6 |
Insights on the role of boron containing moieties in the design of new potent and efficient agonists targeting theß2 adrenoceptor. |
Instituto Polit£Cnico Nacional (Ipn) |
| 25065493 |
92 |
The identification of 7-[(R)-2-((1S,2S)-2-benzyloxycyclopentylamino)-1-hydroxyethyl]-4-hydroxybenzothiazolone as an inhaled long-actingß2-adrenoceptor agonist. |
Novartis Institutes For Biomedical Research |
| 24813741 |
110 |
Multivalent design of long-actingß(2)-adrenoceptor agonists incorporating biarylamines. |
Theravance |
| 24300734 |
12 |
Design, synthesis and evaluation of dual pharmacologyß2-adrenoceptor agonists and PDE4 inhibitors. |
Sun Yat-Sen University |
| 1346651 |
29 |
Synthesis of halogenated trimetoquinol derivatives and evaluation of their beta-agonist and thromboxane A2 (TXA2) antagonist activities. |
Ohio State University |
| 22932315 |
28 |
An investigation into the structure-activity relationships associated with the systematic modification of theß(2)-adrenoceptor agonist indacaterol. |
Novartis Institutes For Biomedical Research |
| 22079756 |
219 |
From libraries to candidate: the discovery of new ultra long-acting dibasicß2-adrenoceptor agonists. |
Astrazeneca |
| 21925889 |
48 |
The discovery of long-acting saligeninß2 adrenergic receptor agonists incorporating a urea group. |
Glaxosmithkline |
| 21696967 |
51 |
The discovery of long-acting saligeninß2 adrenergic receptor agonists incorporating hydantoin or uracil rings. |
Glaxosmithkline |
| 6148422 |
36 |
Synthesis and beta-adrenergic blocking activity of new aliphatic and alicyclic oxime ethers. |
TBA |
| 6134834 |
54 |
Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted-amino)-2-hydroxypropoxy]phenyl]imidazole class. |
TBA |
| 6130154 |
68 |
Ultra-short-acting beta-adrenergic receptor blocking agents. 2. (Aryloxy)propanolamines containing esters on the aryl function. |
TBA |
| 6130153 |
66 |
Ultra-short-acting beta-adrenergic receptor blocking agents. 1. (Aryloxy)propanolamines containing esters in the nitrogen substituent. |
TBA |
| 6120237 |
15 |
2-Benzodioxinylaminoethanols: a new class of beta-adrenergic blocking and antihypertensive agents. |
TBA |
| 6104730 |
47 |
Synthesis and beta-adrenergic blocking activity of new aliphatic oxime ethers. |
TBA |
| 19168263 |
14 |
Synthesis, pharmacological and in silico evaluation of 1-(4-di-hydroxy-3,5-dioxa-4-borabicyclo[4.4.0]deca-7,9,11-trien-9-yl)-2-(tert-butylamino)ethanol, a compound designed to act as a beta2 adrenoceptor agonist. |
Instituto Polit£Cnico Nacional (Ipn) |
| 17845020 |
44 |
Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans. |
Universit£ |
| 7562902 |
114 |
Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications. |
Smithkline Beecham Pharmaceuticals |
| 8230093 |
34 |
Conformationally restrained analogs of sympathomimetic catecholamines. Synthesis, conformational analysis, and adrenergic activity of isochroman derivatives. |
Universit£ |
| 1359141 |
47 |
Synthesis and hypoglycemic activity of substituted 8-(1-piperazinyl)imidazo[1,2-a]pyrazines. |
Merck Sharp And Dohme Research Laboratories |
| 22297114 |
20 |
Dualß2-adrenoceptor agonists-PDE4 inhibitors for the treatment of asthma and COPD. |
Sun Yat-Sen University |
| 21075627 |
26 |
Inhalation by design: dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD. |
Pfizer |
| 21277205 |
26 |
Discovery of substituted phenyl urea derivatives as novel long-actingß2-adrenoreceptor agonists. |
RhôNe-Poulenc Rorer |
| 20402514 |
34 |
The identification of indacaterol as an ultralong-acting inhaled beta2-adrenoceptor agonist. |
Novartis Institutes For Biomedical Research |
| 12873495 |
2 |
Synthesis and preliminary evaluation of (R,R)(S,S) 5-(2-(2-[4-(2-[(18)F]fluoroethoxy)phenyl]-1-methylethylamino)-1-hydroxyethyl)-benzene-1,3-diol ([(18)F]FEFE) for the in vivo visualisation and quantification of the beta2-adrenergic receptor status in lung. |
University Of Mainz |
| 7910217 |
36 |
The [(methyloxy)imino]methyl moiety as a bioisoster of aryl. A novel class of completely aliphatic beta-adrenergic receptor antagonists. |
Universitá |
| 2563296 |
38 |
A new series of tricyclic (aryloximino)propanolamines displaying very high selective beta 2-blocking properties. |
Université |
| 1672155 |
14 |
Effect of fluorine substitution on the adrenergic properties of 3-(tert-butylamino)-1-(3,4-dihydroxyphenoxy)-2-propanol. |
National Institute Of Diabetes |
Search and Browse
